DGX — Quest Diagnostics Income Statement
0.000.00%
Last trade - 00:00
- $14.26bn
- $18.53bn
- $9.25bn
- 86
- 59
- 72
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,726 | 9,437 | 10,788 | 9,883 | 9,252 |
Cost of Revenue | |||||
Gross Profit | 2,724 | 3,717 | 4,278 | 3,465 | 3,066 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,495 | 7,466 | 8,407 | 8,455 | 7,990 |
Operating Profit | 1,231 | 1,971 | 2,381 | 1,428 | 1,262 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,076 | 1,884 | 2,599 | 1,235 | 1,130 |
Provision for Income Taxes | |||||
Net Income After Taxes | 829 | 1,424 | 2,002 | 971 | 882 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 858 | 1,431 | 1,995 | 946 | 854 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 855 | 1,425 | 1,988 | 942 | 850 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.65 | 11.2 | 16.2 | 8.6 | 7.9 |
Dividends per Share |